Recombinant Anti-VEGF Receptor 1 Antibody [Icrucumab Biosimilar] - Azide free (A318839)

Anti-VEGF Receptor 1 Antibody [Icrucumab Biosimilar] - Azide free

Recombinant human monoclonal [Icrucumab Biosimilar] antibody to VEGF Receptor 1.

ELISA, Flow Cytometry

ELISA: 1:5,000-10,000, Flow Cytometry: 1:100

Human

Human

Monoclonal

IgG1

Unconjugated

Reconstitution dependent.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze / thaw cycles.

EC 2.7.10.1, FLT, FLT 1, Flt-1, FLT1, Fms like tyrosine kinase 1, Fms related tyrosine kinase 1, Fms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), Fms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor, Fms-like tyrosine kinase 1, FRT, Soluble VEGF receptor 1 14, Soluble VEGFR1 variant 2, Soluble VEGFR1 variant 21, Tyrosine protein kinase FRT, Tyrosine protein kinase receptor FLT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor vascular permeability factor receptor, Vascular endothelial growth factor/vascular permeability factor receptor, Vascular permeability factor receptor, Vascular permeability factor receptor 1, VEGFR 1, VEGFR-1, VEGFR1, VGFR1_HUMAN